Ticker Symbol: DTIL

Precision Biosciences Inc

$9.69 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: United States Currency: USD Asset Type: Common Stock CIK:0001357874

Company Profile

Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its wholly proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company's pipeline consists of multiple 'off-the-shelf' CAR T immunotherapy clinical candidates and several in vivo gene correction therapy candidates to cure genetic and infectious diseases where no adequate treatments exist.

Sector: Professional, Scientific, and Technical Services

Industry: Research and Development in Biotechnology

Standard Industrial Classification Code (SIC code): 2836

Address: 302 E Pettigrew St Ste A100

Website: precisionbiosciences.com

CEO: Matthew Kane

Tags:

Biotechnology
Health Technology

Pricing

Last Updated: October 3, 2023 03:00 PM EST

Previous Close: $0.32

Change: -$0.01 ( -3.13%)

Days Range: $0.29 - $0.33

Beta: 1.18

52wk. High: $1.70

52wk. Low: $0.28

Ytd. Change -75.20%

50 Day Moving Average: $0.37

200 Day Moving Average: $0.60

Shares Outstanding: 115070517

Valuation

Market Cap: 3.7B

PE Ratio: -0.40

EPS (TTM): -0.7981

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A